REZUM is a minimally invasive surgical treatment (MIST) approved by the FDA for men between the ages of 30 and 80 who suffer from benign prostatic hyperplasia (BPH). It involves the use of thermal energy in the form of steam to induce atrophy and shrinkage of the prostate tissue, thereby relieving urinary symptoms associated with BPH.

Prostate cancer is the most common male cancer in Canada. One out of every 8 men, 12% of all men in Canada, will develop the disease during his lifetime.